Product Code: RP-ID-10059490 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10059490
Market Overview:
Global Animal Antibiotics and Antimicrobials Market Outlook 2030
The worldwide animal antibiotics and antimicrobials market is anticipated to achieve revenue of USD 3 billion in 2021 and is likely to grow at a CAGR of 5% between 2022 and 2030. It is expected that in the next seven years, the increase in demand for livestock products will have a positive impact on the global animal antibiotic and antimicrobial market. Macrolides, tetracyclines, quinolones, penicillins, cephalosporins, sulfonamides and aminoglycosides are different types of animal antibiotics and antimicrobial agents. Tetracycline is an important raw material for antibiotics and has developed rapidly in recent years. Strong demand for penicillin antibiotics is expected to promote the development of animal antibiotics and antibiotics markets. Promote increased demand for animal protein products to help the world market. It is expected that increased animal health and welfare measures will contribute to the overall global animal antibiotics and antibiotics market. More and more animal disease outbreaks are touted as playing a key role in supplementing the global animal antibiotic and antimicrobial market. The increase in the number of livestock is expected to further promote the market for antibiotics and antimicrobial agents for animals.
Terminal industries such as the animal meat industry have grown rapidly in recent years and are expected to experience rapid development during the forecast period. The increase in demand for dairy products is expected to promote the development of the global antibiotic and antibacterial agent market. The US Food and Drug Administration and other agencies; regulations on overuse of antibiotics have been touted as causing slow market growth. The massive use of enzymes in food and feed is expected to hinder the overall growth of the animal antibiotic and antimicrobial market. It is expected that increased competition from this industry will hinder the growth of the world market. Cheaper alternatives on the market are expected to hinder the growth of the animal antibiotic and antimicrobial market.
The rise in antibiotic resistance is a key reason that is expected to hinder the growth of the animal antibiotic and antimicrobial market. Good and sanitary handling practices that lead to a reduction in antibiotic usage are expected to slow the growth of the animal antibiotic and antimicrobial market in the next seven years. It is expected that the large number of industry players that cause severe price wars will reduce profits and reduce the performance of the animal antibiotic and antimicrobial industry. Initiatives to develop new technologies provide ample opportunities for existing and new industry players.
Antimicrobial agents and antibiotics for animals can be administered in a variety of ways, such as oral premixes, powders and solutions, injections, and intramammary preparations. Animal antibiotics and antimicrobial agents are used in many end-use areas, such as dairy products market, animal meat market, personal pet market, livestock market and animal feed market. In recent years, pharmaceutical applications have dominated animal antibiotics and antimicrobial applications, followed by dairy applications. These leading end-use industries are expected to achieve dynamic growth during the forecast period.
North America is the most important regional market for animal antibiotics and antimicrobial drugs, accounting for nearly one-third of total global demand, followed by Europe. This trend is mainly due to the acceleration of urbanization, increased disposable income and increased demand for animal-related products. Developing regions such as the Asia-Pacific, the Middle East, and Africa have seen substantial growth in the past few years, and are expected to achieve strong growth in the next seven years. The market for animal antibiotics and antibacterial agents in Central and South America is also expected to grow rapidly. The strong demand for animal protein and the increase in pet ownership are expected to have a direct impact on the regional market of animal antibiotics and antibacterial agents. It is said that due to the rapid growth of the terminal industry, countries such as China, India, Malaysia, Vietnam, Indonesia and Japan are experiencing strong growth.
Due to the large number of industry participants, the industry is characterized by fierce competition. The major players in the animal antibiotic and antimicrobial industry are Elanco Animal Health, Zoetis Inc., Vetoquinol, Merck And Co. Inc., Boehringer Ingelheim, Ceva Sante Animale, Bayer AG, Novartis AG, Virbac SA, Eli Lilly And Company, and Sanofi .
Related Reports
Proof of Quality & Reliability
